Business
CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing disruptive technologies and products based on its non-animal-derived recombinant human collagen (rhCollagen), today announced the appointment of Bowman Bagley as Vice President, Commercial North America. In this newly created role, Mr. Bagley will lead the company's commercial strategy and execution in North America, including sales and marketing, logistics, and expansion of market presence for Co
About this update from Collplant Biotechnologies Ltd.
[{"type":"text","content":"New U.S.-based role to support growth strategy, partnerships, and scaling of rhCollagen product platforms","length":105,"tagName":"p","attribs":{}},{"type":"text","content":"REHOVOT, Israel, July 14, 2025 /PRNewswire/ — CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing disruptive technologies and products based on its non-animal-derived recombinant human collagen (rhCollagen), today announced the appointment of Bowman Bagley as Vice President, Commercial North America. In this newly created role, Mr. Bagley will lead the company's commercial strategy and execution in North America, including sales and marketing, logistics, and expansion of market presence for CollPlant's rhCollagen-based products and platforms.","length":604,"tagName":"p"},{"type":"image","alt":"Bowman Bagley, Vice President Commercial North America, CollPlant","displaySize":"","headline":null,"caption":"Bowman Bagley, Vice President Commercial North America, CollPlant","credit":"CollPlant","className":"","disableSlideshowImg":false,"size":{"original":{"width":2488,"height":2481,"url":"https://s.yimg.com/os/creatr-uploaded-images/2025-07/da3d45b0-60ae-11f0-bfeb-67a02fb2a4d8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/56gPtGpgi28O7Gr6WK2kCg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk1NztjZj13ZWJw/https://s.yimg.com/os/creatr-uploaded-images/2025-07/da3d45b0-60ae-11f0-bfeb-67a02fb2a4d8","width":960,"height":957},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/4hoZVM12yIBMXJ.yTdqgHQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0yMzk0O2NmPXdlYnA-/https://s.yimg.com/os/creatr-uploaded-images/2025-07/da3d45b0-60ae-11f0-bfeb-67a02fb2a4d8","width":1200,"height":1197}}},{"type":"text","content":""We are excited to welcome Bowman to the CollPlant leadership team as we scale our commercial operations and development programs," said Yehiel Tal, Chief Executive Officer of CollPlant. "His deep expertise in collagen-based biomaterials, 3D bioprinting, and tissue engineering aligns perfectly with our growth strategy. Bowman's proven track record in sales, product development, licensing, and operational execution will be instrumental as we grow our bioinks portfolio and expand rhCollagen sales to the research market as well as to strategic collaborators in the fields of regenerative and aesthetic medici...